Article
Prediction of fetal hemoglobin in sickle cell anemia using an ensemble of genetic risk prediction models.
Circulation. Cardiovascular genetics - 1 Apr 2014
Milton Jacqueline N, Gordeuk Victor R, Taylor James G, Gladwin Mark T, Steinberg Martin H, Sebastiani Paola
Abstract excerpt
BACKGROUND: Fetal hemoglobin (HbF) is the major modifier of the clinical course of sickle cell anemia. Its levels are highly heritable, and its interpersonal variability is modulated in part by 3 quantitative trait loci that affect HbF gene expression. Genome-wide association studies have identified single-nucleotide polymorphisms (SNPs) in these quantitative trait loci that are highly associated with HbF but...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
